Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.
about
Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regenerationSialic acid-binding immunoglobulin-like lectin 7 mediates selective recognition of sialylated glycans expressed on Campylobacter jejuni lipooligosaccharidesAnti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndromeHuman monoclonal immunoglobulin M antibodies to ganglioside GM1 show diverse cross-reactivities with lipopolysaccharides of Campylobacter jejuni strains associated with Guillain-Barré syndromeDevelopment of an immunoassay for rapid detection of ganglioside GM(1) mimicry in Campylobacter jejuni strainsLipopolysaccharides from Campylobacter jejuni O:41 strains associated with Guillain-Barré syndrome exhibit mimicry of GM1 gangliosideSerum antibodies against gangliosides and Campylobacter jejuni lipopolysaccharides in Miller Fisher syndromeChemical validation of molecular mimicry: interaction of cholera toxin with Campylobacter lipooligosaccharides.Capsule polysaccharide conjugate vaccine against diarrheal disease caused by Campylobacter jejuni.Serotyping of Campylobacter jejuni based on heat-stable antigens: relevance, molecular basis and implications in pathogenesis.Monoclonal antibodies raised against Guillain-Barré syndrome-associated Campylobacter jejuni lipopolysaccharides react with neuronal gangliosides and paralyze muscle-nerve preparations.Distinct immunoglobulin class and immunoglobulin G subclass patterns against ganglioside GQ1b in Miller Fisher syndrome following different types of infectionFunctional characterization of a lipoprotein-encoding operon in Campylobacter jejuni.Campylobacter species and Guillain-Barré syndrome.Sialylation of lipooligosaccharide cores affects immunogenicity and serum resistance of Campylobacter jejuniPhase variation of Campylobacter jejuni 81-176 lipooligosaccharide affects ganglioside mimicry and invasiveness in vitroTolerance to self gangliosides is the major factor restricting the antibody response to lipopolysaccharide core oligosaccharides in Campylobacter jejuni strains associated with Guillain-Barré syndrome.Axonal Guillain-Barré syndrome: a critical review.Characterization of the Campylobacter jejuni heptosyltransferase II gene, waaF, provides genetic evidence that extracellular polysaccharide is lipid A core independent.Development of a novel therapy for Lipo-oligosaccharide-induced experimental neuritis: use of peptide glycomimicsO-antigen structural variation: mechanisms and possible roles in animal/plant-microbe interactions.Lipooligosaccharide of Campylobacter jejuni: similarity with multiple types of mammalian glycans beyond gangliosidesGanglioside molecular mimicry and its pathological roles in Guillain-Barré syndrome and related diseasesAnti-GT1a IgG in Guillain-Barré syndrome.Evidence for acquisition of the lipooligosaccharide biosynthesis locus in Campylobacter jejuni GB11, a strain isolated from a patient with Guillain-Barré syndrome, by horizontal exchangeStructural characterization of Campylobacter jejuni lipooligosaccharide outer cores associated with Guillain-Barre and Miller Fisher syndromes.Antiglycolipid antibodies in Guillain-Barré syndrome and related diseases: review of clinical features and antibody specificities.Characterization of α2,3- and α2,6-sialyltransferases from Helicobacter acinonychis.Prospective study on anti-ganglioside antibodies in childhood Guillain-Barré syndromeThe immunobiology of Guillain-Barré syndromes.Guillain-Barré syndrome and anti-ganglioside antibodies: a clinician-scientist's journey.Host-pathogen interactions in Campylobacter infections: the host perspective.Characterization of lipooligosaccharide-biosynthetic loci of Campylobacter jejuni reveals new lipooligosaccharide classes: evidence of mosaic organizations.Multifunctionality of Campylobacter jejuni sialyltransferase CstII: characterization of GD3/GT3 oligosaccharide synthase, GD3 oligosaccharide sialidase, and trans-sialidase activities.Campylobacter sialyltransferase gene polymorphism directs clinical features of Guillain-Barré syndrome.Axonal Guillain-Barré syndrome: carbohydrate mimicry and pathophysiology.Topology and patch-clamp analysis of the sodium channel in relationship to the anti-lipid a antibody in campylobacteriosis.Molecular mimicry: sensitization of Lewis rats with Campylobacter jejuni lipopolysaccharides induces formation of antibody toward GD3 ganglioside.High-performance separation techniques hyphenated to mass spectrometry for ganglioside analysis.Recent developments and future directions in Guillain-Barré syndrome.
P2860
Q26995291-5641D865-5649-4BD5-B05D-04CB725B4697Q28247592-3F493CBD-D3A7-422F-898B-FF40242FC1F8Q28297319-1D2740DE-1567-4D7A-991E-8ED4A9CEBDFCQ28343397-172D417E-9AFD-4D91-B662-AED294159E71Q28361686-4ADBF9B4-79FD-4CB9-878B-9E95DB2E84D4Q28368289-2A0EE553-1D18-4494-94B4-2CE26793D480Q28379144-00FBB3FB-51AE-486A-A8DE-C09A8E0FB32FQ33269357-632F1814-5442-4331-9084-E68A7FCC65DBQ33396432-616D9D2A-173C-4B3F-A56A-48ABB28F2B06Q33590132-B3131044-0F80-46B1-B2E2-7DA870AE0E8BQ33853670-F3725F7D-7D08-451F-B77D-623CA147153AQ33867225-2FA7D6B6-3EC6-4916-9597-AF54D3A4ABDCQ33916158-9051DDE7-92C9-40B7-A23A-10A6EB699559Q33975353-4503CA0F-71AB-409B-8B93-122D1E25320EQ34005157-95931D77-D6E1-46E5-8F3D-1CFC043290DFQ34116680-B7BC5D9B-016F-4E01-91AB-216C789FDFD2Q34129949-C3C12DD0-CD78-4963-B606-CCE9A78CEB3BQ34235801-1DADB147-DD15-4412-A233-7291D83FB5F1Q34308441-F98C8AAB-D13D-46DA-AA98-C162501E24DEQ34451647-19A4A5FA-FB73-4622-AC1A-F70ED09B26B2Q34635579-9473CF98-88B0-45E2-AED2-D699D816EB02Q34752248-55447393-1524-4893-85EA-FD849A905D6CQ35220367-B871405D-88C6-4C5B-875B-C2351ED84268Q35467723-F6BF4ABE-35BB-41B6-8901-86D8B7AEFC7EQ35549851-DA138472-1F64-4EA0-ADB5-57F78C5D64FDQ35689505-52057C40-C30E-41CE-BB00-AAA4C7F7241DQ36019417-8299113B-E00E-4690-BDA1-0EE4EE25E4F0Q36132557-25C4426F-EF52-4A23-9C88-AE287BDDD0CCQ36153916-4301DCE0-FC02-4288-B04F-BCC6D1EDE3F1Q36164122-62A7B25E-275E-4179-AA25-82E290147BA3Q36174702-7669F43A-8701-4695-95EE-5B01D2DF6B7EQ36803887-4D1188AE-643E-4A81-A589-E0EB9C1991DDQ36845068-77FF1315-7E96-4B18-A502-FF070F18327AQ36986469-CC610851-FA7E-4BA7-A662-32040E94BB38Q36994586-9B3DA449-FBE7-42A4-9CA0-54DE130E6E01Q37016196-10662B79-BA56-4F92-96F4-2B145B60775FQ37073308-E8C49B79-1FBF-46FC-AD3E-81FD3E9E3354Q37388398-C23C0292-3504-4E9B-BD15-5409E2C2D4C2Q37878442-885A7D7B-6F24-42A2-A256-F21D2D62DA73Q38070887-74AE9BA5-E44E-4566-825B-D1BF9EB08900
P2860
Lipopolysaccharides of Campylobacter jejuni serotype O:19: structures of core oligosaccharide regions from the serostrain and two bacterial isolates from patients with the Guillain-Barré syndrome.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Lipopolysaccharides of Campylo ...... h the Guillain-Barré syndrome.
@ast
Lipopolysaccharides of Campylo ...... h the Guillain-Barré syndrome.
@en
type
label
Lipopolysaccharides of Campylo ...... h the Guillain-Barré syndrome.
@ast
Lipopolysaccharides of Campylo ...... h the Guillain-Barré syndrome.
@en
prefLabel
Lipopolysaccharides of Campylo ...... h the Guillain-Barré syndrome.
@ast
Lipopolysaccharides of Campylo ...... h the Guillain-Barré syndrome.
@en
P2093
P921
P356
P1433
P1476
Lipopolysaccharides of Campylo ...... h the Guillain-Barré syndrome.
@en
P2093
Aspinall GO
Kurjanczyk LA
McDonald AG
P304
P356
10.1021/BI00167A032
P407
P577
1994-01-01T00:00:00Z